Tag: Luspatercept

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Luspatercept

$-0.64 EPS Expected for Acceleron Pharma Inc. (XLRN)

Added to Collection on: 2018-07-28 06:41:15

Tags for this article:

NASDAQ
Economy of the United States
Biotechnology
Health care
Acceleron Pharma
Celgene
Luspatercept

Click the tags to see associated articles and topics

View Article Details
Analysts See $-0.67 EPS for Acceleron Pharma Inc. (XLRN)

Added to Collection on: 2018-10-16 20:56:15

Tags for this article:

Finance
NASDAQ
Economy of the United States
Acceleron Pharma
Companies
Luspatercept
N-Shares

Click the tags to see associated articles and topics

View Article Details
Why James Levy Sold 12300000 Shares of Laredo Petroleum, Inc. (LPI)?; Acceleron Pharma Inc ...

Added to Collection on: 2018-11-18 02:00:00

Tags for this article:

Money
Finance
Economy
NASDAQ
Short
Laredo, Texas
Acceleron Pharma
Acceleron Pharma Inc.
Luspatercept
N-Shares
XLRN.O

Click the tags to see associated articles and topics

View Article Details
Imara closes $63M Series B funding round for blood disorder drug development

Added to Collection on: 2019-03-17 21:52:30

Tags for this article:

Medicine
Biology
RTT
Gene therapy
Branches of biology
Luspatercept
Sickle-cell disease
Red blood cell
Thalassemia
Hydroxycarbamide
Beta thalassemia
Sickle cell-beta thalassemia

Click the tags to see associated articles and topics

View Article Details
Spark Investment Management LLC Takes $3.91 Million Position in Acceleron Pharma Inc (XLRN)

Added to Collection on: 2019-05-25 20:56:15

Tags for this article:

Financial markets
Stock market
Equity securities
Finance
Financial economics
Acceleron Pharma
Stock
Luspatercept
Share
Price?earnings ratio
Spark Investment Management Llc
Acceleron Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
BlackRock Inc. Has $202.19 Million Stock Position in Acceleron Pharma Inc (NASDAQ:XLRN)

Added to Collection on: 2019-12-12 08:22:30

Tags for this article:

Financial markets
Financial economics
Finance
Acceleron Pharma
Luspatercept
Short
Stock
Acceleron Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Man Group plc Invests $452000 in Acceleron Pharma Inc (NASDAQ:XLRN)

Added to Collection on: 2020-01-01 16:15:00

Tags for this article:

Acceleron Pharma
Luspatercept
Price?earnings ratio
Health care
Companies
Health
Acceleron Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Acceleron Pharma (NASDAQ:XLRN) Price Target Raised to $135.00 at Morgan Stanley

Added to Collection on: 2020-12-16 17:14:50

Tags for this article:

Financial markets
Acceleron Pharma
Financial economics
Luspatercept
Stock
Finance

Click the tags to see associated articles and topics

View Article Details
Global Thalassemia Treatment Market is estimated to be US$ 14.7 billion by 2030 with a CAGR of ...

Added to Collection on: 2021-04-30 14:09:29

Tags for this article:

Branches of biology
Genetic genealogy
Medical genetics
Hemoglobins
Thalassemia
Alpha-thalassemia
Beta thalassemia
Anemias
Hemoglobin subunit beta
Bluebird bio
Luspatercept
Gene therapy

Click the tags to see associated articles and topics

View Article Details
Long-term Treatment With Luspatercept Reduces Transfusion Dependence Associated ... - OncLive

Added to Collection on: 2022-06-12 16:40:23

Tags for this article:

Bristol-Myers Squibb
Luspatercept
Transfusion medicine
Beta thalassemia
Medical specialties
Clinical medicine
Branches of biology

Click the tags to see associated articles and topics

View Article Details